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objective. Surveillance of nosocomial infections (NIs) is well established in many countries but often does not include gastrointestinal
infections. We sought to determine the proportion of NIs among all hospitalized cases for the 4 most prevalent types of gastrointestinal
infections in Germany.
methods. We analyzed all notifications of laboratory-confirmed or epidemiologically linked gastrointestinal infections due to norovirus,
rotavirus, Salmonella species, and Campylobacter species reported to the Robert Koch Institute in Berlin, Germany, from 2002 through
2008. Infections were considered nosocomial if disease onset was more than 2 days after hospitalization for norovirus, rotavirus, and
Salmonella infection and more than 5 days after hospitalization for Campylobacter infection.
results. During the study period, 710,725 norovirus, 394,500 rotavirus, 395,736 Salmonella, and 405,234 Campylobacter gastrointestinal
infections were reported. Excluding cases for which nosocomial status could not be determined, we identified 39,424 (49%) of 80,650
norovirus, 11,592 (14%) of 83,451 rotavirus, 3,432 (8%) of 43,348 Salmonella, and 645 (2%) of 33,503 Campylobacter gastrointestinal
infections as definite nosocomial cases. Multivariate analysis confirmed higher risk of gastrointestinal NIs for patients aged more than 70
years (relative risk [RR], 7.0 [95% confidence interval {CI}, 6.7–7.2]; ) and residents of western states (RR, 1.3 [95% CI, 1.2–1.3];P ! .001
) and lower risk for female patients (RR, 0.9 [95% CI, 0.9–0.9; ). Yearly NI proportions remained stable except for norovirus.P ! .001 P ! .001
conclusions. The investigated gastrointestinal NIs in Germany do not show a clear trend, but they are at high level, revealing potential
for public health action and improvement of hospital infection control mainly among older patients. National prevalence studies on
gastrointestinal NIs would be of additional value to give more insight on how and where to improve hospital infection control.
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A nosocomial infection (NI) is an infection acquired by a
patient in a hospital or other healthcare facility.1,2 NIs are a
substantial burden both for the patient and for public health.1
The estimated prevalence of NIs among hospitalized patients
in Germany in 1994 was 3.5%.3 To our knowledge, only 3
published studies on the prevalence of NIs also address gas-
trointestinal NIs: the prevalence of gastrointestinal NIs in
general hospitals was found to be 0.4% in Italy,4 4.1% in
Greece,5 and 3.5% on average (stratified by ward, 0%–13%)
in a point-prevalence study performed in France.6 We there-
fore aimed to investigate the role of NIs among the 4 most
prevalent types of gastrointestinal infections captured within
the notifiable disease surveillance system in Germany from
2002 through 2008 and to identify changes over time and
possible risk groups, which might lead to improved preven-
tion of gastrointestinal NIs.
methods
Local health departments receive notifications from labora-
tories or clinicians, verify the cases according to the national
case definitions, and forward them electronically to the Rob-
ert Koch Institute in Berlin, Germany, via the state health
departments on a single-case basis with information on the
patient’s age, sex, laboratory diagnosis, hospitalization status,
and so forth.7 Data transfer within the German surveillance
system is anonymous.
We included all cases of norovirus, rotavirus, Salmonella,
and Campylobacter infection reported to the Robert Koch
Institute from 2002 through 2008 for which information on
hospitalization status was available. According to the national
case definition, a case of acute gastroenteritis was either con-
firmed by a laboratory or epidemiologically linked to a lab-
oratory-confirmed case.8
We determined that a case was nosocomial by taking into
account the time between admission to the hospital and dis-
ease onset with reference to the mean incubation period9-13
of the pathogen, according to definitions of NI used by the
Centers for Disease Control and Prevention and the World
Health Organization.1,2 Norovirus, rotavirus, and Salmonella
infections with disease onset more than 2 days after hospital
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table 1. Characteristics of Study Population and Proportion of Nosocomial Infections (NIs) for the 4 Most Prevalent Types of
Gastrointestinal Infection (GI) in Germany, 2002–2008
Characteristic Norovirus Rotavirus Salmonella Campylobacter
All reported GIs 710,725 394,500 395,736 405,234
All reported GIs with known hospitalization
status (% of all reported GIs) 699,463/710,725 (98) 391,167/394,500 (99) 391,302/395,736 (99) 401,195/405,234 (99)
Cases involving hospitalization (% of all reported
GIs with known hospitalization status) 179,941/699,463 (26) 158,578/391,167 (41) 91,497/391,302 (23) 52,662/401,195 (13)
Study population after exclusions
(% of cases involving hospitalization) 90,849/179,941 (50) 90,335/158,578 (57) 46,955/91,497 (51) 35,896/52,662 (68)
Non-NIs (% of study population) 41,226/90,849 (45) 71,859/90,335 (80) 39,916/46,955 (85) 32,858/35,896 (92)
Probable NIs (% of study population) 10,199/90,849 (11) 6,884/90,335 (8) 3,607/46,955 (8) 2,393/35,896 (7)
Definite NIs (% of study population) 39,424/90,849 (43) 11,592/90,335 (13) 3,432/46,955 (7) 645/35,896 (2)
Final study population without probable NIs
(% of cases involving hospitalization) 80,650/179,941 (45) 83,451/158,578 (53) 43,348/91,497 (47) 33,503/52,662 (64)
Definite NIs (% of final study population) 39,424/80,650 (49) 11,592/83,451 (14) 3,432/43,348 (8) 645/33,503 (2)
note. Data are proportion (%) of cases, unless otherwise indicated.
figure 1. Hospitalization rates of all reported cases (A) and pro-
portions of definite nosocomial infections (B) in the final study
population for the 4 most prevalent types of gastrointestinal infection
in Germany according to year, 2002–2008.
admission and Campylobacter infections with disease onset
more than 5 days after admission were considered to have
been acquired nosocomially. Norovirus, rotavirus, and Sal-
monella infections with disease onset 1–2 days after admission
and Campylobacter infections with disease onset 2–5 days after
admission were considered probable NIs.
The study population included only cases with known hos-
pitalization status and dates of hospitalization and disease
onset. We excluded the following cases for which the patient
was hospitalized long before or after the gastrointestinal in-
fection, which would probably have been community ac-
quired: cases with (1) disease onset more than 3 days before
hospitalization for norovirus, Salmonella, and rotavirus gas-
trointestinal infections and more than 6 days before hospi-
talization for Campylobacter gastrointestinal infections, be-
cause those are community acquired and not related to
hospitalization; (2) disease onset later than 25.5 days after
hospitalization, because these cases would be highly unlikely
nosocomial, taking into account the mean length of hospi-
talization in Germany; or (3) disease onset more than 3 days
after hospital discharge for norovirus, Salmonella, and rota-
virus gastrointestinal infections and more than 6 days after
hospital discharge for Campylobacter gastrointestinal infec-
tions, because these cases again would not be nosocomial,
taking into account the incubation periods of the pathogens.
Furthermore, we excluded probable NIs, because their nos-
ocomial status could not be proven, so the final study pop-
ulation contained only all cases that were definitely noso-
comial or definitely not nosocomial (Table 1). Within the
final study population, we calculated proportions of definite
NIs for each pathogen and also stratified by sex, age group
(less than 1, 1, 2, 3, 4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–
39, 40–49, 50–59, 60–69, and more than 69 years), and yearly
and geographical distribution. For multivariate analysis, we
used a quartile distribution of age groups. For geographical
distribution, we stratified between eastern states (Berlin,
Brandenburg, Mecklenburg-Vorpommern, Sachsen, Sachsen-
Anhalt, and Thüringen) and western states (Baden-Württem-
berg, Bayern, Bremen, Hamburg, Hessen, Niedersachsen,
Rheinhard-Pfalz, Saarland, and Schleswig-Holstein). Multi-
variate analysis was performed to analyze risk factors and to
control for confounding factors.
For the evaluation of the data, we used Excel (Microsoft),
and statistical analyses (forward logistic regression including
all variables) were performed in SPSS, version 15 (SPSS). All
P values are 2-sided, and a P value of less than .05 was
considered to reveal a significant difference using the Wald
test.
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figure 2. Proportions of cases of infection in each age group of the final study population that were definitely nosocomial (A) and
age distribution of definite nosocomial infections (B) for the 4 most prevalent types of gastrointestinal infection in Germany, 2002–2008.
results
A total of 710,725 cases of norovirus gastrointestinal infec-
tion, 394,500 cases of rotavirus gastrointestinal infection,
395,736 cases of Salmonella gastrointestinal infection, and
405,234 cases of Campylobacter gastrointestinal infection were
reported from 2002 through 2008 in Germany, resulting in
annual incidences of 123.2, 68.4, 68.6, and 70.3 cases per
100,000 population, respectively (Table 1). Hospitalization
status was known for 98% of norovirus infections and for
99% of rotavirus, Salmonella, and Campylobacter infections.
Among those cases with known hospitalization status, 26%
of norovirus cases, 41% of rotavirus cases, 23% of Salmonella
cases, and 13% of Campylobacter cases involved hospitali-
zation (Table 1). The hospitalization rate among all reported
cases increased during the observed time period, especially
for norovirus infection (from 4% to 37%); slightly increasing
trends are also seen for rotavirus (from 13% to 19%) and
Campylobacter (from 13% to 18%), whereas the rate of hos-
pitalization for Salmonella infection was stable (Figure 1A).
Of cases involving hospitalization, 45% of norovirus, 53%
of rotavirus, 47% of Salmonella, and 64% of Campylobacter
cases were included in the final study population. The pro-
portions of definite NIs were 49%, 14%, 8%, and 2%, re-
spectively (Table 1).
Our results show that the proportions of rotavirus, Sal-
monella, and Campylobacter NIs in the final study population
remained stable over time, whereas the proportions of no-
rovirus NIs showed fluctuating patterns (Figure 1B). In the
final study population, there was no sex difference in the
proportions of definite NIs for infections due to rotavirus,
Salmonella, and Campylobacter, but for infections due to no-
rovirus, the proportion of NIs was 47% (16,391 of 34,907)
among male patients and 50% (23,003 of 45,663) among
female patients. The geographical distribution of definite NIs
within the final study population showed higher proportions
for norovirus, rotavirus, and Salmonella NIs in western states
(50% [22,423 of 45,056], 15% [7,446 of 50,590], and 10%
[3,055 of 31,600], respectively) than in eastern states (48%
[16,995 of 35,582], 13% [4,146 of 32,858], and 3% [376 of
11,745], respectively), whereas Campylobacter NIs did not
show any geographical difference. The age distribution of
definite NIs due to norovirus and rotavirus in the final study
population shows a U-shaped allotment—infections due to
these pathogens were most often definitely nosocomial among
patients aged less than 1 year (16% [906 of 5,729] for no-
rovirus and 16% [4,576 of 27,941] for rotavirus) or more
than 69 years (65% [25,933 of 39,992] for norovirus and 41%
[2,699 of 6,642] for rotavirus). The proportions of Salmonella
and Campylobacter NIs slowly increased with age—infections
due to these pathogens were most often definitely nosocomial
in patients aged more than 69 years (13% [1,137 of 8,555]
and 5% [289 of 5,775], respectively) (Figure 2A). We also
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table 2. Multivariable Analysis of Definite Nosocomial Infections for 4 Most Prevalent Types of Gastrointestinal Infection and Their












RR (95% CI) P RR (95% CI) P RR (95% CI) P RR (95% CI) P RR (95% CI) P
Sex distribution
Male Reference Reference Reference
Female 0.9 (0.9–0.9) !.001 0.9 (0.9–0.9) !.001 1.0 (0.9–1.0) .03
Geographic distribution
East Reference Reference Reference
West 1.3 (1.2–1.3) !.001 1.3 (1.3–1.4) !.001 3.3 (3.0–3.7) !.001
Agea
Quartile 1 Reference Reference Reference 0.3 (0.3–0.4) !.001 Reference
Quartile 2 0.6 (0.6–0.6) !.001 8.5 (8.1–8.9) !.001 0.5 (0.4–0.5) !.001 0.3 (0.3–0.3) !.001 1.7 (1.2–2.4) .004
Quartile 3 3.9 (3.8–4.1) !.001 14.3 (13.5–15.0) !.001 0.3 (0.3–0.4) !.001 0.6 (0.6–0.7) !.001 3.3 (2.4–4.5) !.001
Quartile 4 7.0 (6.7–7.2) !.001 13.0 (12.4–13.6) !.001 1.6 (1.5–1.7) !.001 Reference 7.5 (5.6–10.0) !.001
Yearly incidence
2002 Reference Reference Reference 0.8 (0.7–0.9) .004
2003 0.9 (0.8–0.9) !.001 0.6 (0.5–0.7) !.001 1.0 (0.9–1.1) .95 0.8 (0.7–0.9) .004
2004 0.8 (0.8–0.9) !.001 0.5 (0.5–0.6) !.001 1.0 (0.9–1.1) .48 0.9 (0.8–1.0) .23
2005 0.8 (0.7–0.8) !.001 0.5 (0.4–0.5) !.001 0.9 (0.9–1.0) .054 0.8 (0.7–0.9) .004
2006 0.8 (0.7–0.8) !.001 0.6 (0.5–0.7) !.001 0.9 (0.8–0.9) !.001 0.8 (0.7–0.9) .002
2007 0.8 (0.8–0.8) !.001 0.6 (0.5–0.6) !.001 0.9 (0.8–0.9) !.001 Reference
2008 0.7 (0.7–0.7) !.001 0.5 (0.5–0.6) !.001 0.8 (0.6–0.9) !.001 0.7 (0.7–0.8) !.001
note. CI, confidence interval; RR, relative risk.
a Age quartiles consist of the following ranges: all pathogens: X1, 1–20, 21–70, and 170 years; norovirus: X25, 26–69, 70–81, and 181 years; rotavirus:
prenatal, 0–1, 2–3, and 13 years; Salmonella: X6, 7–25, 26–65, and 165 years; Campylobacter: X19, 20–34, 35–62, and 162 years.
calculated the age distribution of definite NIs due to each
pathogen and determined that the highest load of norovirus,
Salmonella, and Campylobacter NIs also occurred in patients
aged more than 69 years (66% [25,933 of 39,424], 33% [1,137
of 3,432], and 45% [289 of 645], respectively), but the highest
load of rotavirus NIs occurred in patients aged less than 1
year (39% [4,576 of 11,592]) or 1 year (15% [1,762 of
11,592]) (Figure 2B).
Multivariate analysis of definite NIs (Table 2) confirmed
higher risk of NI with increasing age, especially for patients
aged more than 70 years (relative risk [RR], 7.0 [95% con-
fidence interval {CI}, 6.7–7.2]; ), and higher risk ofP ! .001
NI in western states (RR, 1.3 [95% CI, 1.2–1.3]; ).P ! .001
In comparison with NI due to norovirus, the risks of NI due
to rotavirus (RR, 0.4 [95% CI, 0.4–0.5]; ), SalmonellaP ! .001
(RR, 0.1 [95% CI, 0.1–0.1]; ), and CampylobacterP ! .001
(RR, 0.02 [95% CI, 0.02–0.02]; ) were lower. In con-P ! .001
trast to the results of the descriptive analysis, the risk of NI
due to all pathogens was slightly lower for female patients
(RR, 0.9 [95% CI, 0.9–0.9]; ) than for male patients.P ! .001
discussion
To our knowledge, this analysis is the first population-based
assessment of gastrointestinal NIs. The proportions of NIs in
Germany are high (49% of norovirus, 14% of rotavirus, 8%
of Salmonella, and 2% of Campylobacter gastrointestinal in-
fections). In Europe, mainly rotavirus infections have been
studied in this sense: the median proportion of rotavirus NIs
among all hospital admissions in Europe ranges from 0.3%
to 27.7%14 and among rotavirus-associated hospitalizations
from 21% to 27%.15,16
Our results show that NIs are particularly prevalent in the
very young and the very old. Ford-Jones et al17 found that
in children, gastrointestinal infections usually account for
17%–20% of NIs, whereas in adults, NIs occur less often in
the gastrointestinal tract.3,4 Our estimates for NIs as a pro-
portion of the final study population in patients aged less
than 1 year were higher for norovirus and rotavirus infections
(16% for each) and lower for Salmonella and Campylobacter
infections (6% and 2%, respectively). In the elderly popu-
lation, we observed NI proportions as high as 65% for no-
rovirus gastrointestinal infections and 41% for rotavirus gas-
trointestinal infections, whereas the proportion of NIs among
Salmonella and Campylobacter gastrointestinal infections were
much lower (13% and 5%, respectively).
For norovirus infections, the elderly and immunocompro-
mised patients are more often18,19 and more severely affected,
whereas, unlike with rotavirus infections, neonates and very
young children are rarely affected.20 This is supported by our
study, in which 66% of all norovirus NIs occurred among
the elderly, whereas only 0.5% occurred among children aged
less than 9 years. These age-related differences suggest that
patients with more intensive care during hospitalization may
be more exposed to nosocomial transmission.
Interestingly, the proportions of NIs due each pathogen
did not show much yearly shift in Germany, except norovirus.
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The proportion of norovirus NIs among all norovirus-as-
sociated hospitalizations was high (49% overall), and it de-
creased substantially from 2002 to 2004 but then increased
again in 2007. This fact is interesting in combination with
the finding that the rate of hospitalization for norovirus in-
fection increased sharply in 2007 (33%) and 2008 (37%) in
comparison with 2002–2003 (4%). We believe that the de-
creasing trend might be partly explained by improved hospital
hygiene since 2002. The new increase of norovirus NIs after
2006 is probably due to the global spread of GII.4 strains that
triggered winter epidemics in 2006–2007, 2007–2008, and
2008–200921-23 and overwhelmed the hospitals’ capacity to
stop further spread of the disease within the facilities.
We have difficulty explaining why the proportions of ro-
tavirus and Salmonella NIs were significantly higher in west-
ern Germany (RR, 1.3 [95% CI, 1.3–1.4]; ; and RR,P ! .001
3.3 [95% CI, 3.0–3.7]; , respectively) than in easternP ! .001
Germany: generally, surveillance sensitivity for gastrointes-
tinal infections is higher in eastern than in western Germany,24
which could result in a higher denominator when proportions
of NIs are calculated. We did not find any significant geo-
graphical difference in hospitalization length of stay. Fur-
thermore, geographical differences may reflect not only sur-
veillance differences but also different management styles,
thus revealing potential for general improvement.
The high proportion of NIs among the 4 types of gastro-
intestinal infections in Germany indicates a need for im-
provement in hospital infection control. Although it is known
that hand hygiene is an effective means of preventing NIs,
adherence among patients, patients’ visitors, and healthcare
workers might be poor.25 Therefore, we suggest additional
support for hospital-wide programs promoting hand hygiene
and other control measures for the prevention of NIs.1,10,26-31
Our study had some limitations. Data on hospitalization
were not available for all patients, but we do not expect that
the factors leading to incomplete capture of hospitalization
data would bias the analysis. Our definition of NI was based
simply on the incubation period for each pathogen; none-
theless, these differ according to infectious dose and health
status of the host. For the NI analysis, we used a very specific
definition of NI to ensure that only definite NIs were ana-
lyzed. We also did not account for infections occurring after
hospital discharge. For these reasons, the true proportion of
NIs is likely to be even larger than that described here.
Gastrointestinal NIs do not show a clear trend but are
frequent in Germany. This indicates that hospital infection
control needs to be improved and suggests that gastrointes-
tinal infections should be addressed by surveillance and in-
fection control programs in hospitals. National prevalence
studies on gastrointestinal NIs and analysis of outbreaks
caused by these pathogens would complete the data presented
and would help to specify the improvements needed in hos-
pital infection control in Germany.
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